Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplementation for Depression
NCT02466087Phase 3Completed
- Sponsor
- The University of Vermont
- Start
- May 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by The University of Vermont. Primary endpoint: Patient Health Questionnaire-9 at 12 weeks. Started May 2015; status: completed.
Beyond the preview
Go deeper on NCT02466087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466087.